Serious violations and manipulations of the trial protocol: This is how Pfizer managed to obtain the FDA’s emergency authorization for children
by Yaffa Shir-Raz Analysis and comparison of the review document submitted by Pfizer to the US Food and Drug Administration, on the basis of which the FDA gave the green light to expand the emergency permit for vaccination, as well, for children aged 12-15, as opposed to the study protocol in children, reveal concerning findings,…